Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

An Immunocompetent Murine Model of Metastatic Mammary Cancer Accessible to Bioluminescence Imaging

MASA-AKI SHIBATA, EIKO SHIBATA, JUNJI MORIMOTO, NABIL A.S. EID, YOSHIHISA TANAKA, MASAHITO WATANABE and YOSHINORI OTSUKI
Anticancer Research November 2009, 29 (11) 4389-4395;
MASA-AKI SHIBATA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: shibatam{at}art.osaka-med.ac.jp an1000{at}art.osaka-med.ac.jp
EIKO SHIBATA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JUNJI MORIMOTO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NABIL A.S. EID
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOSHIHISA TANAKA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAHITO WATANABE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOSHINORI OTSUKI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: shibatam{at}art.osaka-med.ac.jp an1000{at}art.osaka-med.ac.jp
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    a, The kinetics of photon production from a single tumor of a mouse after intraperitoneal injection with D-luciferin salts. The graph shows a peak signal 8-15 min after luciferin injection; we therefore chose to image 10 min after luciferin injections. The values plotted were integrated every 1 second. b, The relative mammary tumor volumes in female BALB/c mice. c, Histogram of the photon counts in mammary tumors from female BALB/c mice. d, Analysis of the correlation between tumor volume and photon count; Pearson's correlation r=0.95.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    a and b, Sequential bioluminescent imaging in representative individual animals. Note that the increased intensity of the bioluminescent signals correlated with increased tumor size. a, The right axillary region (arrow) showed signal at 6 weeks while the right mandibular region (arrow) and left femoral region (arrow) bioluminesced 8 weeks post-inoculation in animal #2. b, Animal #3 showed signals in both the axillary (arrows) and left femoral regions (arrow) at 9 weeks post-inoculation. c-h, Histopathologies of the primary mammary carcinoma (c, ×200) and of metastases (d-h). The primary tumor arising at the inoculation site proved to be a moderately differentiated adenocarcinoma (animal #2). Within the same mouse, metastases developed in the mandibular lymph node (d, ×100), the axillary lymph node (e, ×100), and the femoral lymph node (f, ×100) — all of which were detected in imaging in the ventral plane. However, small metastatic foci found upon necropsy in the lungs of animal #2 (g, ×40) and the ovary from animal #3 (h, ×100) were not detected in ventral bioluminescence imaging. c-h, H&E stain.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    a-f, Correlation of bioluminescent imaging and macroscopic and histological findings in representative mice. With animal #5 placed in the venter up position, the signals observed in regions corresponding to the primary tumor (*) and lymph nodes (a, black arrows indicate axillary, mandibular, iliac, and femoral lymph nodes) correlated to macroscopic abnormalities at necropsy findings (b, * and black arrows). Furthermore, focal signals (a, white arrows) appeared to emanate from prominent vessels observed at necropsy (b, white arrows) and may indicate tumor cells present in the lumens of distended lymphatic vessels (g, arrows, ×400) as seen with podoplanin immunohistochemistry. Dorsal imaging successfully detected macroscopic abnormalities in the kidneys and adrenals not apparent with ventral imaging of animal #5 (c); metastasis was histologically confirmed in femoral lymph nodes (h, ×400), lungs (i, ×40), kidney (j, ×40), and adrenals (k, ×200). In animals #1 and #4, luminescence was detected in areas corresponding to mandibular, axillary, and femoral lymph nodes (d and e); the large area of signal seen in animal #1 in panel f corresponded to liver metastasis (l, ×100). g, podoplanin immunohistochemistry; h-l, H&E stain.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    The incidence of metastasis (a) and the relative numbers of metastases by organ and mouse (b) as assessed by histopathological examination. Metastatic incidence in lymph nodes, in lungs, and in adrenals was 90, 80 and 70%, respectively (a, b). The number of lung metastatic foci >250 μm in size were counted (b).

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 29, Issue 11
November 2009
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
An Immunocompetent Murine Model of Metastatic Mammary Cancer Accessible to Bioluminescence Imaging
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
An Immunocompetent Murine Model of Metastatic Mammary Cancer Accessible to Bioluminescence Imaging
MASA-AKI SHIBATA, EIKO SHIBATA, JUNJI MORIMOTO, NABIL A.S. EID, YOSHIHISA TANAKA, MASAHITO WATANABE, YOSHINORI OTSUKI
Anticancer Research Nov 2009, 29 (11) 4389-4395;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
An Immunocompetent Murine Model of Metastatic Mammary Cancer Accessible to Bioluminescence Imaging
MASA-AKI SHIBATA, EIKO SHIBATA, JUNJI MORIMOTO, NABIL A.S. EID, YOSHIHISA TANAKA, MASAHITO WATANABE, YOSHINORI OTSUKI
Anticancer Research Nov 2009, 29 (11) 4389-4395;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Bioluminescence Imaging of Adoptively Transferred Lymphocytes During Allogeneic Tumor Rejection
  • Therapy with siRNA for Vegf-c but Not for Vegf-d Suppresses Wide-spectrum Organ Metastasis in an Immunocompetent Xenograft Model of Metastatic Mammary Cancer
  • Targeted Therapy of VEGFR2 and EGFR Significantly Inhibits Growth of Anaplastic Thyroid Cancer in an Orthotopic Murine Model
  • Google Scholar

More in this TOC Section

  • 6-O-Carboxypropyl-α-Tocotrienol Enhances the Anticancer Effects of Bortezomib Without Suppressing NRF1 and NRF3 in Colorectal Cancer Cells
  • Imbalance Between CD44 and STAT3 Enhances Spheroid Viability and Impairs Pembrolizumab Response in Urothelial Cancer
  • Imipramine Targets Apoptosis, Metastasis, and EGFR/SRC-mediated EMT in Oral Cancer Cells
Show more Experimental Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire